All subjects pretreated with n-dodecyl-β-D-maltoside survived lethal flu/ antibiotic-resistant bacteria doses

https://www.eurekalert.org/news-releases/1116142

"immune-priming agent rather than direct pathogen targeting... more rapidly recruits/ more effectively activates neutrophils (1st-line defense cells) to infection site... untreated control group had 0% survival rate... immune activation only triggers in pathogen's presence, avoiding chronic inflammation/ overstimulation in healthy states... alternative to antibiotics/ vaccines, pathogen agnostic: not hindered by viral mutations/ drug resistance... critically ill in ICUs, immunocompromised, elderly, future pandemics"